# Study to Assess the Safety and Efficacy of CD-NP in the Treatment of Patients With Acute Decompensated Heart Failure

> **NCT00839007** · PHASE2 · COMPLETED · sponsor: **Nile Therapeutics** · enrollment: 77 (actual)

## Conditions studied

- Acute Decompensated Heart Failure

## Interventions

- **DRUG:** CD-NP

## Key facts

- **NCT ID:** NCT00839007
- **Lead sponsor:** Nile Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2010-06
- **Final completion:** 2010-07
- **Target enrollment:** 77 (ACTUAL)
- **Last updated:** 2010-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00839007

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00839007, "Study to Assess the Safety and Efficacy of CD-NP in the Treatment of Patients With Acute Decompensated Heart Failure". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00839007. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*